Found 207 matching trials
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE2 Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors PHASE1 This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer PHASE2 This 2 arms study will compare the efficacy and safety of treatment with se...
Show More Location
Service de Pneumologie, CHU Angers
Learn More & Join Trial
Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma PHASE2 Both pemetrexed and erlotinib are second-line treatment options for patient...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) PHASE2 This Phase II, multicenter, randomized trial is designed to make preliminar...
Show More Location
Comprehensive Blood and Cancer Center (TORI)
Learn More & Join Trial
Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer PHASE2 RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Show More Location
University of Colorado Cancer Center at UC Health Sciences Center
Learn More & Join Trial
MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy PHASE1 RATIONALE: MET/VEGFR2 inhibitor Foretinib and erlotinib hydrochloride may s...
Show More Location
BCCA - Vancouver Cancer Centre
Learn More & Join Trial
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). PHASE2 This 4 arm study in patients with advanced Stage IIIb/IV non-small cell can...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting PHASE2 Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Show More Location
Scottsdale Healthcare Research Institute
Learn More & Join Trial